Protein C - Takeda
Alternative Names: Ceprotin; Protein C; Protein C concentrate; TAK 662Latest Information Update: 04 Apr 2024
At a glance
- Originator Hyland Immuno
- Developer KM Biologics; Takeda
- Class Anticoagulants; Antithrombotics; Biological factors; Blood proteins; Enzyme precursors; Glycoproteins
- Mechanism of Action Protein C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Protein C deficiency